Anti-smoking aid to boost Bioglan
Monday 15 February 1999
The "nicotine sniffer" - a nasal spray - promises to become the latest weapon in millions of people's daily struggle to give up smoking.
The device, currently being developed by the Hertfordshire-based company, uses a burst of highly-pressurised gas to deliver a nicotine dose into the nose.
According to Terry Sadler, the chief executive, the sniffer is more effective than traditional methods such as nicotine patches because the sprayed liquid is absorbed by the mucose in the nose and gets directly into the bloodstream.
Bioglan, which came to the market in December with a pounds 200m flotation, is planning to launch the product in the next 18 months. Mr Sadler believes the sniffer could become a powerful competitor to patches and other therapies aimed at the nine million Britons who try to give up smoking every year.
Bioglan is in talks with a number of pharmaceutical companies who want to buy the rights to the sniffer, Mr Sadler said. The market for aids to quit smoking has boomed over the past few years as people and governments have become more health-conscious.
It is estimated that the 1.1bn smokers across the world spend $500m (pounds 312m) a year on nicotine replacement therapies. In Britain, almost three- quarters of the 13m adult smokers say they would like to stop.
The Government has recently launched an anti-smoking campaign, high- lighting the huge social and economic cost of the habit.
According to Government figures, more than 120,000 people a year die from smoking, with hundreds more killed by passive smoking. The habit costs the NHS pounds 1.7bn each year and the Government believes the problem could get worse as more and more young people take up smoking.
The sniffer is a departure from Bioglan's traditional markets. The group specialises in dermatology and last year boosted its portfolio of skin- care drugs with the pounds 16m purchase of a batch of products from the pharmaceutical giant Zeneca.
The company is believed to be looking at expanding its portfolio of 50 products with a US acquisition.
- 1 Exclusive: Abusers using spyware apps to monitor partners reaches 'epidemic proportions'
- 2 Margaret Thatcher 'expressed fears of Asian rising' at Anglo-Irish summit in 1984
- 3 The 'Black Museum': After 150 years, public set to see exhibits from police’s grisly crime museum
- 4 The Unluckiest People of the Year 2014 (and one very unlucky giraffe)
- 5 Magna Carta will be 800 years old next year – the perfect reminder of the rights and freedoms we must hold dear
Exclusive: Abusers using spyware apps to monitor partners reaches 'epidemic proportions'
UK weather: Warning for more snow and ice as freezing temperatures and gales hit Britain
Margaret Thatcher 'expressed fears of Asian rising' at Anglo-Irish summit in 1984
UK weather: Travel chaos continues as King's Cross train delays add to snow on roads
The Unluckiest People of the Year 2014 (and one very unlucky giraffe)
British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
Rozanne Duncan: Ukip expels councillor for 'jaw-dropping' comments made in BBC TV interview
Germany anti-Islam protests: 17,000 march on Dresden against 'Islamification of the West'
Ukip member gets into Christmas spirit with Union Flag plea to Santa 'for our country back'
Immigrants make UK racist, says Ukip councillor Trevor Shonk
BBC director Danny Cohen: Rising UK antisemitism makes me feel more uncomfortable than ever
iJobs Money & Business
Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...
Not specified: Selby Jennings: Quantitative Research | Global Equity | New Yor...
Not specified: Selby Jennings: SVP Model Validation This top tiered investment...
Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...